A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Applying to Pennsylvania Regional Center for Arthritis & Osteoporosis Research · Wyomissing, Pennsylvania
Answer a few short questions to share with the research team.